IC
LABD icon

Ikarian Capital’s Direxion Daily S&P Biotech Bear 3X ETF LABD Stock Holding History

Ikarian Capital’s Portfolio LABD Stock Details LABD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$816K Hold
105,822
– – 0.09% 114
2026
Q1 		$1.72M Buy
105,822
+65,000
+159% +$1.23M 0.14% 105
2025
Q4 		$860K Sell
40,822
-51,137
-56% -$1.39M 0.07% 129
2025
Q3 		$3.72M Buy
+91,959
New +$5.33M 0.38% 71

Other funds holding LABD

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return
JF
Jump Financial Chicago, Illinois $12.4B AUM 62.79% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
GS
GTS Securities Miami, Florida $4.75B AUM 41.97% 1-Year Est. Return

Ikarian Capital's LABD Position: Q2 2026 in Review

Ikarian Capital held its Direxion Daily S&P Biotech Bear 3X ETF (LABD) position steady in Q2 2026 at 105,822 shares worth $816K. The position accounts for 0.09% of the portfolio, ranked #114.

Ikarian Capital first reported a position in LABD in Q3 2025 and has held it in 4 quarters since. The position peaked at $3.72M in Q3 2025. 21 funds tracked by Wall St. Rank hold LABD as of Q2 2026.

  • Ikarian Capital held 105,822 shares of Direxion Daily S&P Biotech Bear 3X ETF worth $816K as of Q2 2026.
  • Ikarian Capital left its Direxion Daily S&P Biotech Bear 3X ETF share count unchanged in Q2 2026.
  • Direxion Daily S&P Biotech Bear 3X ETF made up 0.09% of Ikarian Capital's portfolio in Q2 2026, its #114 holding.
  • Ikarian Capital first reported a position in Direxion Daily S&P Biotech Bear 3X ETF in Q3 2025 and has held it in 4 quarters since.
  • Ikarian Capital's Direxion Daily S&P Biotech Bear 3X ETF position peaked at $3.72M in Q3 2025.
  • 21 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bear 3X ETF as of Q2 2026.

Based on Ikarian Capital's 13F filing for Q2 2026, filed 14 Aug 2026.